About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

Gene Therapy Can Treat Hereditary Hearing Loss

by Hannah Joy on September 23, 2017 at 2:47 PM
Font : A-A+

Gene Therapy Can Treat Hereditary Hearing Loss

There is now possible hope for children with hereditary hearing loss by using gene therapy. In France, one child in 700 is born with severe or profound hearing loss, and one in every 1,000 will lose their sense of hearing before adulthood.

Worldwide, more than 280 million people are affected with hearing loss, which is the most common sensory deficit and is sometimes linked with other disorders like balance defects, reveals WHO.

Advertisement


Over the past 20 years, scientists have made remarkable progress in deciphering the genetic origins of congenital hereditary hearing loss, which is usually caused by inner ear dysfunction.

The inner ear comprises the hearing organ or cochlea, together with the five balance organs (the saccule, utricle and three semicircular canals), which contain the sensory cells, or hair cells, that detect mechanical vibrations and convert them into electrical signals.
Advertisement

To date, mutations in more than 100 genes have been associated with inner ear defects, and it is estimated that mutations in more than 100 genes can cause genetic forms of deafness.

The various hereditary forms of hearing loss include Usher syndrome type 1 (USH1), a particularly severe clinical form of deaf-blindness, and specifically the USH1G genetic form.

USH1G patients are profoundly deaf and have no balance function at birth, and they subsequently suffer from prepubertal-onset sight loss leading to blindness. USH1G syndrome is due to mutations in the gene encoding the scaffold protein sans, which is essential for the cohesion of the hair bundle of the inner ear hair cells.

Patients with hearing loss and balance dysfunction are currently fitted with auditory prostheses and may be given balance rehabilitation therapy, but the outcomes are variable.

One possible alternative for treating such hereditary inner ear defects is gene therapy. This approach entails transferring a healthy (non-mutant) copy of the defective gene to restore the expression of the missing protein.

So far, gene therapy attempts have only resulted in partial improvements of hearing in mouse models of specific human deafness forms that did not include severe anomalies in hair cell structure.

In this context, scientists from the Institut Pasteur, Inserm, the CNRS, Collège de France, University Pierre et Marie Curie, and University Clermont Auvergne*, have now succeeded in restoring hearing and balance in a mouse model of USH1G syndrome using gene therapy.

With a single local injection of the USH1G gene just after birth, the scientists observed a restoration of the structure and mechanosensory function of the inner ear hair bundles profoundly damaged before birth, resulting in a long-term partial recovery of hearing, and complete recovery of vestibular function in these mice. These results unexpectedly establish that inner ear defects due to major morphogenetic abnormalities of the hair bundle can be reversed even after birth, with durable efficacy, by gene therapy.

The scientists injected the USH1G gene into the inner ear using the innocuous AAV8 virus, which enabled them to specifically target the hair cells. The expression of the therapeutic gene was detected 48 hours after injection.

The team demonstrated that a single injection to restore the production and localization of the missing protein in hair cells successfully improved hearing and balance functions in the young mice. These findings suggest that the therapeutic protein was able to interact normally with its binding partners among the USH1 molecular complex (the proteins cadherin 23, protocadherin 15, myosin VIIA and harmonin), as required for the mechanoelectrical transduction apparatus of the hair bundle to function correctly.

As Saaïd Safieddine, CNRS Director of Research at the Institut Pasteur and co-senior author of the study with Prof. Christine Petit (head of the Genetics & physiology hearing unit at the Institut Pasteur), explains, "we have just shown that it is possible to partially correct a specific form of hereditary hearing loss accompanied by balance problems using local gene therapy performed after the embryogenesis of the ear, which is primarily affected by the mutation responsible for the disorder. This suggests that the time window for effectively treating USH1 syndrome using gene therapy may be larger than initially thought."

This study represents a significant step towards the development of clinical trials in gene therapy for the curative treatment of hereditary deafness and balance loss in humans.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
News Category
What's New on Medindia
Printed Temperature Sensors help with Continuous Temperature Monitoring
Health Benefits of Giloy
Breast Cancer Awareness Month 2021 - It's time to RISE
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
DNA Finger Printing Tinnitus Presbycusis Reiki and Pranic Healing Genetic Testing of Diseases Pancreas Acoustic Neuroma Meniere’s Disease Hearing Aids Hearing Tests in Newborns 

Recommended Reading
Sodium Thiosulfate Prevents Cisplatin-Induced Hearing Loss in Children With Cancer
Sodium thiosulfate prevents cisplatin-induced hearing loss in children and adolescents with cancer, ...
Law Aids Picking Up Hearing Loss in Infants Due to Congenital Cytomegalovirus
A Utah law has led to increased early identification of infants with hearing loss due to a ......
Hearing Loss Rapidly Accelerates Over the Age of 90
The use of hearing aid among older population should be increased because the untreated hearing ......
Elderly With Undiagnosed Hearing Loss Suffer from Social Isolation
A ten-decibel reduction of hearing sensitivity in elderly was also associated with cognitive ......
Acoustic Neuroma
Acoustic neuroma is a benign intercranial tumor involving the myelin-forming Schwann cells of the ...
DNA Finger Printing
DNA fingerprinting is a technique which helps forensic scientists and legal experts solve crimes, id...
Genetic Testing of Diseases
Genetic testing helps to confirm a genetic condition in an individual and involves q complex laborat...
Hearing Aids
Hearing aid is an electronic device that helps people with hearing loss to hear more and communicate...
Hearing Tests in Newborns
Ideally, screening tests for hearing loss should be conducted before the infant is 1 month of age....
Meniere’s Disease
Meniere’s disease is a condition of unknown cause in which the patient experiences symptoms of verti...
Presbycusis
Presbycusis (age related hearing loss) is the gradual loss of hearing that occurs as people get olde...
Tinnitus
Tinnitus is the perception of ringing, hissing, or other sound within the ears when no corresponding...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use